Latest Breaking News On - Alpha therapies - Page 1 : comparemela.com

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

SYDNEY (BUSINESS WIRE) #CMO AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of

United statesSan franciscoStanford universityAnna karmannAndrew adamovichMckinsey companyTsinghua universityBristol myers squibbMaastricht universityUniversity medical center maastrichtStanford university hospitalAachen universityTargeted alpha therapiesChief medical officerInvestigational new drugAlpha therapies

ICPO Foundation Reporting on Successful 3rd ICPO Forum for Theranostics in Precision Oncology Held at Garching, Munich on October 12th and 13th, 2023

ICPO Foundation Reporting on Successful 3rd ICPO Forum for Theranostics in Precision Oncology Held at Garching, Munich on October 12th and 13th, 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South africaUnited statesNew delhiFlorian herrmannIndiens wirtschaftMatthias eiberInkosi albert luthuliOliver sartorSanjana ballalAndrew scottRichardp baumIhre chancenMike sathekgeOdile jaumeUdoj vetterRichard henkelmann

Serva Energy Discovers Promising New Way to Produce Cancer-killing Actinium-225 Isotope

/PRNewswire/ Serva Energy, a nuclear innovation company, has developed a new production method to ramp up the supply of Actinium-225, a cancer-killing.

Serva energyisBrian hornIan horvathDepartment of energy national isotope development centerPrnewswire serva energyDepartments of nuclear medicineServa energyOffice of isotope rd productionUs department of energy isotope programTargeted alpha therapiesSenior associate consultantMayo clinic rochesterNuclear medicineAlpha therapiesNational isotope development centerMayo clinic

AdvanCell Closes A$18M Series B Funding Led by Morningside

Series B financing will accelerate growth and advance lead clinical program 212Pb-ADVC001 a best-in-class treatment for metastatic prostate cancer, expand manufacturing platform footprint and progress

United statesCity ofUnited kingdomNorth lanarkshireAndrew adamovichKostenloser wertpapierhandelAdrian adi pattersonAnthony aiudiKevin cameronAustralian nuclear scienceResearch development tax incentiveTechnology organisationHealth medical devices fundTargeted alpha therapyCancer treatmentAlpha therapies

Orano Med Inaugurates the Extension of the Maurice Tubiana Laboratory and its Research & Development Center

Orano Med Inaugurates the Extension of the Maurice Tubiana Laboratory and its Research & Development Center
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Claude imauvenMarc quesnoyKostenloser wertpapierhandelJulien dodetMaurice tubiana laboratoryResearch development centerRegulatory newsTargeted alpha therapiesAlpha therapiesOrano medஆராய்ச்சி வளர்ச்சி மையம்ஒழுங்குமுறை செய்திஇலக்கு ஆல்பா சிகிச்சைகள்ஆல்பா சிகிச்சைகள்ஓராணோ மேட்